Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4441626
Max Phase: Preclinical
Molecular Formula: C22H24FN5O6
Molecular Weight: 473.46
Molecule Type: Unknown
Associated Items:
ID: ALA4441626
Max Phase: Preclinical
Molecular Formula: C22H24FN5O6
Molecular Weight: 473.46
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1nc2[nH]c(CCCCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3F)cc2c(=O)[nH]1
Standard InChI: InChI=1S/C22H24FN5O6/c23-15-9-12(19(31)26-16(21(33)34)7-8-17(29)30)6-5-11(15)3-1-2-4-13-10-14-18(25-13)27-22(24)28-20(14)32/h5-6,9-10,16H,1-4,7-8H2,(H,26,31)(H,29,30)(H,33,34)(H4,24,25,27,28,32)/t16-/m0/s1
Standard InChI Key: STXAYXIUQRNEBG-INIZCTEOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 473.46 | Molecular Weight (Monoisotopic): 473.1711 | AlogP: 1.59 | #Rotatable Bonds: 11 |
Polar Surface Area: 191.26 | Molecular Species: ACID | HBA: 6 | HBD: 6 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.20 | CX Basic pKa: 4.84 | CX LogP: 0.61 | CX LogD: -4.60 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.23 | Np Likeness Score: -0.29 |
1. Ravindra M, Wilson MR, Tong N, O'Connor C, Karim M, Polin L, Wallace-Povirk A, White K, Kushner J, Hou Z, Matherly LH, Gangjee A.. (2018) Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis., 61 (9): [PMID:29701475] [10.1021/acs.jmedchem.8b00408] |
Source(1):